ROK Resources Inc. (TSXV:ROK)
Canada flag Canada · Delayed Price · Currency is CAD
0.2000
-0.0050 (-2.44%)
Aug 13, 2025, 2:27 PM EDT

Inozyme Pharma Revenue

ROK Resources had revenue of 18.14M CAD in the quarter ending March 31, 2025, with 1.69% growth. This brings the company's revenue in the last twelve months to 73.94M, up 2.19% year-over-year. In the year 2024, ROK Resources had annual revenue of 73.63M, down -1.31%.

Revenue (ttm)
73.94M
Revenue Growth
+2.19%
P/S Ratio
0.61
Revenue / Employee
14.79M
Employees
5
Market Cap
44.81M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202473.63M-977.52K-1.31%
Dec 31, 202374.61M-165.58K-0.22%
Dec 31, 202274.78M71.98M2,570.48%
Dec 31, 20212.80M2.34M509.93%
Dec 31, 2020459.09K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro